Yulia V. Meshkova

Lavrent'ev Av
Novosibirsk, NVS 630090, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Design, synthesis, and structural characterization of covalent tetrahydroquinoline-based inhibitors of coronavirus 3CLpro.

Design, synthesis, and structural characterization of covalent tetrahydroquinoline-based inhibitors of coronavirus 3CLpro.

Journal: Bioorganic chemistry
Published: June 26, 2026

Synthesis and cytotoxicity studies of substituted ester-, amide- and urea-type ursane hybrids containing a 1,2,3-triazole linker.

Synthesis and cytotoxicity studies of substituted ester-, amide- and urea-type ursane hybrids containing a 1,2,3-triazole linker.

Journal: Steroids
Published: April 26, 2026

Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors.

Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors.

Journal: Biosensors
Published: March 25, 2026

Synthesis and structure-activity relationship evaluation of hypoglycemic activity of novel borneol and isoborneol containing (hydroxyphenyl)propanoic acids as FFAR1 agonists.

Synthesis and structure-activity relationship evaluation of hypoglycemic activity of novel borneol and isoborneol containing (hydroxyphenyl)propanoic acids as FFAR1 agonists.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Published: November 26, 2025

Lipophilic Substances of the Leaves and Inflorescences of Centaurea scabiosa L.: Their Composition and Activity Against the Main Protease of SARS-CoV-2.

Lipophilic Substances of the Leaves and Inflorescences of Centaurea scabiosa L.: Their Composition and Activity Against the Main Protease of SARS-CoV-2.

Journal: Molecules (Basel, Switzerland)
Published: October 23, 2025

Design and Biological Evaluation of Monoterpene-Conjugated (S)-2-Ethoxy-3-(4-(4-hydroxyphenethoxy)phenyl)propanoic Acids as New Dual PPARα/γ Agonists.

Design and Biological Evaluation of Monoterpene-Conjugated (S)-2-Ethoxy-3-(4-(4-hydroxyphenethoxy)phenyl)propanoic Acids as New Dual PPARα/γ Agonists.

Journal: Molecules (Basel, Switzerland)
Published: October 23, 2025

Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi-, Thiosemicarbazides and 1,3,4-Oxadiazoles.

Synthesis and Cytotoxic Activity of Novel Hybrids of Dehydroabietic Acid With Semi-, Thiosemicarbazides and 1,3,4-Oxadiazoles.

Journal: Chemistry & biodiversity
Published: September 19, 2025

Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR-1 Agonists.

Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR-1 Agonists.

Journal: Archiv der Pharmazie
Published: June 20, 2025

The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses.

The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses.

Journal: Viruses
Published: November 27, 2023

Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of ((Benzyloxy)phenyl)propanoic Acid Bearing an Aminobornyl Moiety.

Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of ((Benzyloxy)phenyl)propanoic Acid Bearing an Aminobornyl Moiety.

Journal: International journal of molecular sciences
Published: April 04, 2023

Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies.

Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies.

Journal: Pharmaceutics
Published: March 27, 2023

Hepatoprotective Effect of a New FFAR1 Agonist-N-Alkylated Isobornylamine.

Hepatoprotective Effect of a New FFAR1 Agonist-N-Alkylated Isobornylamine.

Journal: Molecules (Basel, Switzerland)
Published: December 14, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026